M&A Deal Summary

Ginkgo Bioworks Acquires Zymergen

On July 25, 2022, Ginkgo Bioworks acquired information technology company Zymergen for 300M USD

Acquisition Highlights
  • This is Ginkgo Bioworks’ 1st transaction in the Information Technology sector.
  • This is Ginkgo Bioworks’ largest (disclosed) transaction.
  • This is Ginkgo Bioworks’ 5th transaction in the United States.
  • This is Ginkgo Bioworks’ 1st transaction in California.

M&A Deal Summary
Date 2022-07-25
Target Zymergen
Sector Information Technology
Buyer(s) Ginkgo Bioworks
Deal Type Add-on Acquisition
Deal Value 300M USD
Advisor(s) Cowen Group, Inc. (Financial)
Freshfields Bruckhaus Deringer (Legal)

Target

Zymergen

Emeryville, California, United States
Zymergen is a science and material innovation company rethinking biology and reimagining the world. The company partners with nature to create never-before-imagined materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more. It creates sustainable materials that are in use today, delivering value for Fortune 1000 companies with over $1 billion worth of products using Zymergen microbial innovations sold to date. Zymergen was formed in 2013 and is based in Emeryville, California.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ginkgo Bioworks

Boston, Massachusetts, United States
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks was established in 2008 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 7 of 14
Sector (Information Technology) 1 of 2
Type (Add-on Acquisition) 7 of 11
State (California) 1 of 2
Country (United States) 5 of 11
Year (2022) 4 of 6
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-06 Bitome

Boston, Massachusetts, United States

Bitome is a Boston-based company that is digitizing bioprocessing. Bitome's AI engine leverages metabolomics to rapidly accelerate process optimization helping biotech companies get their product to market faster. Bitome is based in Boston, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-04 Circularis

Oakland, California, United States

Circularis is a biotechnology company with a proprietary circular RNA and promoter screening platform. The company's novel biology has enabled new scales of experimental methods to help customers make advancements in gene therapy and the treatment of rare diseases. Its advanced understanding of circular RNA across multiple cell types and organisms has guided the design toward a range of novel circular RNA materials for use in the growing field of RNA therapeutics. Circularis is based in Oakland, California.

Buy -
Mergr

Product

Company

Legal